期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心房颤动合并心力衰竭的药物治疗 被引量：1

下载PDF
导出
摘要 心房颤动和心力衰竭是当代影响人类健康的两种主要心血管病。心房颤动可诱发和加重心力衰竭，心力衰竭可触发和持续心房颤动，两者互为因果，形成恶性循环，严重影响患者的预后。据文献报道，在一般人群中两者合并存在的发生率约〉1．0%，但随着年龄增大和心功能恶化而发生率逐步增高。约42名的心房颤动患者可发生心力衰竭；
作者 鲁端
机构地区 浙江大学医学院附属邵逸夫医院心内科
出处 《心电学杂志》 2008年第1期14-16,共3页 Journal of Electrocardiology(China)
关键词 持续心房颤动 心力衰竭 药物治疗 心房颤动患者 心血管病 人类健康 恶性循环 一般人群
分类号 R541.75 [医药卫生—心血管疾病] R541.6 [医药卫生—内科学]
  • 相关文献

参考文献17

  • 1Akoum N, Hamdan MH. Atrial fibrillation and congestive heart failure: a two-way street. Curr Heart Fail Rep,2007, 4: 78-83. 被引量：1
  • 2Neuberger HR, Mewis C, van Veldhuisen DJ, et al. Management of atrial fibrillation in patients with heart failure. Eur Heart J, 2007, 28: 2568-2577. 被引量：1
  • 3Maisal WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology pathophysiology, and rationale for therapy. Am J Cardiol, 2003, 91: 2D-8D. 被引量：1
  • 4Kareti KR, Chiong JR, Hsu SS, et al. Congestive heart failure and atrial fibrillation: rhythm versus rate control. J Cardiac Fail, 2005, 11: 164-171. 被引量：1
  • 5戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量：380
  • 6Dries DL, Exner DV, Gersh B J, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction : a retrospective analysis of the SOLVD trials. J Am Coll Cardiol, 1998, 32: 695-703. 被引量：1
  • 7Olsson LG, Swedberg K, Ducharme A, et al. on behalf of the CHARM Investigators. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results form the Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. J Am Coll Cardiol, 2006, 47: 1997-2004. 被引量：1
  • 8Kober L, Swedberg K, McMurray JJ, et al. Previously known and newly diagnosed atrial fibrillation : a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail , 2006,8: 591-598. 被引量：1
  • 9鲁端.心房颤动的现代药物治疗策略[J].全科医学临床与教育,2007,5(5):353-357. 被引量：3
  • 10Corley SD,Epstein AE,DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow - UP Investigation of Rhythm Management (AFFIRM) Study. Circulation, 2004,109: 1509-1513. 被引量：1

二级参考文献54

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量：1399
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量：90
  • 3李莉,孙宝贵,谭宁,郭林妮.全国心房颤动规范化治疗研讨会纪要[J].中华心血管病杂志,2007,35(7):684-685. 被引量：4
  • 4[2]Fuster V,Roden LE,Cannom DS,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary[J].Eur Heart J,2006,27(16):1979-2030. 被引量：1
  • 5[4]Kakar P,Boos CJ,Lip GY.Management of atrial fibrillation[J].Vasc Health Risk Manag,2007,3(1):109-116. 被引量：1
  • 6[9]Verma A,Natale A,Padanilam B J,et al.Why atrial fibrillation ablation should be considered first-line therapy for some patients[J].Circulation,2005,112(8):1214-1222. 被引量：1
  • 7[10]Rivera RJ.Atrial fibrillation:rhythm vs.rate control[J].Arch Cardiol Mex,2006,76(Suppl 2):S193-195. 被引量：1
  • 8[11]Dinh T,Nieuwlaat R,Tieleman RG,et al.Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners,internists and cardiologists in the Netherlands-The EXAMINE-AF study.A questionnaire survey[J].Int J Clin Pract,2007,61(1):24-31. 被引量：1
  • 9[12]Ariesen MJ,Algra A,Kappelle LJ.Antiplatelate drugs in the secondary prevention after stroke:differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2[J].Stroke,2006,37(1):134-138. 被引量：1
  • 10[13]Juurlink DN.Drug interactions with warfarin:what clinicians need to know[ J ].CMAJ,2007,177 (4):369-371. 被引量：1

共引文献4058

同被引文献29

  • 1Wang TJ,Larson MG,Levy D,et al.Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality:the Framingham heart study[J].Circulation,2003,107:2920. 被引量：1
  • 2Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke:the Framingham Study[J].Stroke,1991,22:983. 被引量：1
  • 3Nanborger HR,Mewis C,van Veldhuisen DJ,et al.Management of atrial fibrillation in patients with heart failure[J].Eur Heart J,2007,28:2568. 被引量：1
  • 4Kareti KR,Chiong JR,Hsu SS,et al.Congestive heart failure and atrial fibrillation:rhythm versus rate control[J].J Cardiac Fail,2005,11:164. 被引量：1
  • 5Maisal WH,Stevenson LW.Atrial fibrillation in heart failure:epidemiology,pathophysiology,and rationale for therapy[J].Am J Cardiol,2003,91(6A):2D. 被引量：1
  • 6Tsang Ts,Gersh BJ,Appleton CP,et al.Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women[J].J Am Coll Cardiol,2002,40(9):1636. 被引量：1
  • 7Miyasaka Y,Barnes ME,Gersh BJ,et al.Incidence and mortality risk of congestive heart failure in atrial fibrillation patients:a community-based study over two decades[J].Eur Heart J,2006,27:936. 被引量：1
  • 8Carson PE,Johnson GR,Dunkman WB,et al.The influence of atrial fibrillation on prognosis in mild to moderate heart failure.The V-HeFT Studies.The V-HeFT VA Cooperative Studies Group[J].Circulation,1993,87(6 Suppl):Ⅵ102. 被引量：1
  • 9Costantini M,Ranieri AT,Fachechi C,et al.Atrial fibrillation and heart failure:a complex relationship[J].G ltal Cardiol(Rome),2006,7(1):40. 被引量：1
  • 10Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008.The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology[J].EuroHeart J,2008,29:2388. 被引量：1

引证文献1

二级引证文献20

心电学杂志
2008年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部